Part 2: From Discovery to Delivery: The Next Frontier in Cancer Innovation

Cancer treatment is entering a period of transformation unlike any before. Rapid advances in functional genomics, targeted therapies, next-generation diagnostics, and emerging AI applications are converging to make possible increasingly precise, individualized treatment strategies tailored to a patient’s unique biology. Realizing the full potential of these breakthroughs, however, requires more than scientific progress. This session will bring together perspectives from researchers, industry, funders, investors, and patient advocates to explore where the next wave of innovation will come from and how new models of cross-sector collaboration can translate into real-world impact. The discussion will examine how to expand access, close persistent gaps, and ensure that cutting-edge advances deliver meaningful and equitable benefits for patients worldwide.